Real-world survival of patients treated with taxane therapy after exposure to immunotherapy and platinum-based chemotherapy for advanced non-small-cell lung cancer without actionable mutations
Titel:
Real-world survival of patients treated with taxane therapy after exposure to immunotherapy and platinum-based chemotherapy for advanced non-small-cell lung cancer without actionable mutations
Auteur:
Liu, S.V. Hu, X. Chirovsky, D. Meng, W. Samkari, A.
Verschenen in:
ESMO real world data and digital oncology
Paginering:
Jaargang 3 () nr. C pagina's p.
Jaar:
2024
Inhoud:
Uitgever:
The Author(s), Merck Sharp & Dohme LLC., a subsidiary of Merck & Co., Inc., Rahway, NJ, USA